Review Article | | open
Prospects for strain-specific immunotherapy
Reviews findings of progression of amyloid and tau pathology, targeting Aβ and tau by immunotherapy, and the option of combination therapy as potential treatment for AD. Read the paper in full.
Rice University Department of Bioengineering
University of British Columbia (UBC)
Institute of Molecular Biology (IMB), Mainz, Germany
The Francis Crick Institute